Keywords: altana, boosts, protonix, forecast, germany-based, revised, upwards
Altana boosts Protonix forecast
Article | 05 August 2002
Germany-based Altana has revised upwards its full-year 2002 salesforecast for the blockbuster anti-ulcer treatment Protonix/Pantozol (pantoprazole). The company says that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
